LIPOSOMAL DRUG DELIVERY - ADVANTAGES AND LIMITATIONS FROM A CLINICAL PHARMACOKINETIC AND THERAPEUTIC PERSPECTIVE

被引：108
作者：
FIELDING, RM [1 ]
机构：
[1] LIPOSOME TECHNOL INC, PHARMACOL TOXICOL GRP, MENLO PK, CA USA
来源：
CLINICAL PHARMACOKINETICS | 1991年 / 21卷 / 03期
关键词：
D O I：
10.2165/00003088-199121030-00001
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
[No abstract available]
引用
收藏
页码：155 / 164
页数：10
相关论文
共 81 条
[1]   LIPOSOME DISPOSITION INVIVO .6. DELIVERY TO THE LUNG [J].
ABRA, RM ;
HUNT, CA ;
LAU, DT .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1984, 73 (02) :203-206
[2]  
AHMAD I, 1989, INDIAN J BIOCHEM BIO, V26, P351
[3]   LIPOSOMES WITH PROLONGED CIRCULATION TIMES - FACTORS AFFECTING UPTAKE BY RETICULOENDOTHELIAL AND OTHER TISSUES [J].
ALLEN, TM ;
HANSEN, C ;
RUTLEDGE, J .
BIOCHIMICA ET BIOPHYSICA ACTA, 1989, 981 (01) :27-35
[4]  
ALVING CR, 1986, MED APPLICATION LIPO, P105
[5]  
[Anonymous], 1988, LIPOSOMES DRUG CARRI
[6]   LIPOSOMES WITH ENTRAPPED DOXORUBICIN EXHIBIT EXTENDED BLOOD RESIDENCE TIMES [J].
BALLY, MB ;
NAYAR, R ;
MASIN, D ;
HOPE, MJ ;
CULLIS, PR ;
MAYER, LD .
BIOCHIMICA ET BIOPHYSICA ACTA, 1990, 1023 (01) :133-139
[7]  
BARD DR, 1985, CLIN EXP RHEUMATOL, V3, P237
[8]   INTERACTIONS OF LIPOSOMES WITH SERUM-PROTEINS [J].
BONTE, F ;
JULIANO, RL .
CHEMISTRY AND PHYSICS OF LIPIDS, 1986, 40 (2-4) :359-372
[9]  
BRADFIELD JWB, 1984, MICROSPHERES DRUG TH, P25
[10]   DOXORUBICIN AND 5-FLUOROURACIL PLASMA-CONCENTRATIONS AND DETECTABILITY IN PAROTID-SALIVA [J].
CELIO, LA ;
DIGREGORIO, GJ ;
RUCH, E ;
PACE, J ;
PIRAINO, AJ .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 24 (02) :261-266
123456789